Auris Medical to Host Key Opinion Leader Meeting on

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Auris Medical to Host Key Opinion Leader Meeting on Tinnitus Treatments on March 13 in New York City

ZUG, Switzerland, March 11, 2015 (GLOBE NEWSWIRE) -- Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced that it will host a Key Opinion Leader breakfast focused on current advances in tinnitus treatments. The event and live webcast will take place on Friday, March 13 from 8:00am-9:30am Eastern Time in New York City.

The meeting will feature a live testimonial from a patient diagnosed with tinnitus, followed by a keynote presentation by Michael D. Seidman, MD, who will discuss recent emerging therapies for tinnitus. Members of the Auris Medical executive management team will provide an overview of the Company's technology and ongoing clinical development work with AM-101 for the treatment of acute inner ear (peripheral) tinnitus.

The event is intended for institutional investors and sell-side analysts.  To reserve a place, please contact Veronica Molina at 212-915-2567 or via e-mail at vmolina@lifesciadvisors.com . A live webcast and subsequent replay of the event will also be available at http://lifesci.rampard.com/20150313/reg.jsp , and will be accessible through the Investors section of the Company's website at http://www.aurismedical.com .

Michael D. Seidman, MD, FACS is an internationally recognized tinnitus and inner-ear specialist. He is currently the Director of Research, Medical Director of the Center for Integrative Medicine and Medical Director of Wellness at the Henry Ford Health System. Dr. Seidman is considered an expert on the molecular basis of aging, noise induced hearing loss and tinnitus. He currently sits on the Board of Directors for the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS). He is Co-Editor for the International Tinnitus Journal and is on the Editorial Review Board for eight major otolaryngology (ENT) journals and has more than 100 major publications. He has been an investigator in several clinical trials, including one with AM-101.  He was awarded by the AAO-HNS with the Clinical Practitioner Excellence Award, which is given to one otolaryngologist each year.

About Auris Medical

Auris Medical is a Swiss biopharmaceutical company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology. The Company is currently focusing on the development of treatments for acute inner ear tinnitus (AM-101) and for acute inner ear hearing loss (AM-111) by way of intratympanic injection with biocompatible gel formulations. In addition, Auris Medical is pursuing early-stage research and development projects. The Company was founded in 2003 and is headquartered in Zug, Switzerland. The shares of Auris Medical Holding AG trade on the NASDAQ Global Market under the symbol "EARS".

Forward-looking Statements

This press release may contain statements that constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements are statements other than historical fact and may include statements that address future operating, financial or business performance or Auris Medical's strategies or expectations. In some cases, you can identify these statements by forward-looking words such as "may," "might," "will," "should," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "projects," "potential," "outlook" or "continue," and other comparable terminology. Forward-looking statements are based on management's current expectations and beliefs and involve significant risks and uncertainties that could cause actual results, developments and business decisions to differ materially from those contemplated by these statements. These risks and uncertainties include, but are not limited to, the timing and conduct of clinical trials of Auris Medical's product candidates, the clinical utility of Auris Medical's product candidates, the timing or likelihood of regulatory filings and approvals, Auris Medical's intellectual property position and Auris Medical's financial position, including the impact of any future acquisitions, dispositions, partnerships, license transactions or changes to Auris Medical's capital structure, including future securities offerings. These risks and uncertainties also include, but are not limited to, those described under the caption "Risk Factors" in Auris Medical's prospectus relating to its Registration Statement on Form F-1, as amended, and future filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date they are made, and Auris Medical does not undertake any obligation to update them in light of new information, future developments or otherwise, except as may be required under applicable law. All forward-looking statements are qualified in their entirety by this cautionary statement.

Contact: Dr. Thomas Meyer, Chairman and CEO, +41 41 729 71 94, ear@aurismedical.com

Auris Medical KOL Breakfast New York City http://hugin.info/160190/R/1902051/676202.pdf

HUG#1902051

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fayetteville Auction Puts Two Retail Sites Into Play

Updated Category News Views 0

Two lots staring across Sycamore Dairy Road are about to get a public price tag, and that is usually where the real estate story stops being polite. Iron Horse Auction Co. plans to sell a commercial showroom at 3618 Sycamore Dairy Road and a former batting cage facility at 3701 Sycamore Dairy Road through an online-only auction closing Dec. 9 beginning at 2 p.m. They sit...

Continue Reading
Ambition Links Call Scoring to the Coaching Room Faster

Updated Category News Views 91

A sales call dies twice when nobody turns the recording into practice. First it ends with the prospect, then it vanishes into a pile of transcripts, dashboards, and manager good intentions. Ambition’s new Call Intelligence feature is aimed squarely at that second failure. It brings Gong calls, transcripts, scorecards, and trackers into Ambition’s coaching workflow,...

Continue Reading
Fapon’s Enzyme Push Meets Diagnostics Reality at AMP

Updated Category News Views 110

Enzymes rarely get applause at industry meetings, but they can quietly decide whether a diagnostic workflow behaves or becomes a lab headache. Fapon used its AMP 2026 appearance in Seattle to make that unglamorous case: better enzyme design may help assays move faster and keep working when samples get messy. The company wrapped up the November 10–14 meeting after...

Continue Reading
Getac's Linux Certification Matters at the Rugged Edge

Updated Category News Views 21

Field computers rarely get applause, but they can decide whether a critical operation runs cleanly or turns into a very expensive mess. Getac’s November 19 announcement that its UX10, G140, and V120 rugged devices are certified for Red Hat Enterprise Linux is not the sort of headline that sends investors pounding the table. It is, however, the kind of plumbing work that...

Continue Reading
Swell Partners' Awards Highlight Culture, Not Metrics

Updated Category News Views 31

Recognition Lands in a Crowded Talent Market Two shiny Stevie trophies do not pay payroll, but they can say something useful about a company trying to stand out in the noisy talent-services business. Swell Partners has been named 2026 Company of the Year in Business Services and has seen founder and CEO Cari Gatto receive Best Female CEO of the Year. For a private firm...

Continue Reading
Fox Hill Steel Marks a Long Public-Building Road Ahead

Updated Category News Views 70

A signed steel beam is a fine civic moment, but it is not the finish line. Burlington’s new Fox Hill Elementary School has reached its topping-off milestone, with the structural steel now in place for a 91,000-square-foot, two-story facility intended to serve roughly 325 kindergarten-through-fifth-grade students. That is tangible progress, the sort nobody can fake with...

Continue Reading
Snowrise Targets the Blind Spots in CPG Sales Data

Updated Category News Views 163

A sales total can look healthy while the floorboards are quietly rotting underneath it. That is the uncomfortable CPG problem Snowrise is aiming at: brands know what moved last quarter, but often cannot identify which stores, channels, communities, or promotions actually created the result. Plenty of management teams still steer by topline revenue, net distribution gains,...

Continue Reading
Sysco's Northern California Labor Deal Gets Bigger

Updated Category News Views 135

One hundred forty-four drivers may not rattle a giant food distributor by themselves, but labor agreements have a habit of growing legs. Sysco's Northern California and Nevada regional contract has added members from Teamsters Locals 386 and 431, bringing its coverage above 1,100 workers. For investors watching Sysco, this is less about one afternoon's headline and more...

Continue Reading
Carbonization Furnaces Turn Waste Rules Into Demand

Updated Category News Views 0

Smoke has become an expensive habit for farmers, mills, and municipalities. That is the real commercial backdrop for carbonization furnaces, not some glossy green-tech slogan. MarketsandMarkets estimates this small global equipment market at $310 million in 2026 and projects $510 million by 2031, a 10.2% compound annual growth rate. For a capital-equipment niche, that is...

Continue Reading
Weatherford Adds Grant Roach to Its Sports Deal Team

Updated Category News Views 76

Sports investing has reached that awkward middle age where everybody sees the runway, but few can explain exactly where the bumps are. Weatherford Capital’s decision to bring Grant Roach aboard as vice president is not a headline packed with transaction fireworks. It is, however, a pretty clear tell: the Tampa firm intends to put more bodies and more underwriting muscle...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring SpaceX's Possible IPO and Its Strategic Implications

Updated Category News Views 194

SpaceX's Strategic Inflection Point SpaceX is signaling preparation for a potential public offering, marking a significant change for one of the most important private companies in the aerospace industry. Although Chief Financial Officer Bret Johnsen has not confirmed an IPO, the message shifts the conversation from mere speculation to a focus on conditional execution....

Continue Reading
Exploring Intel's Options Trading Dynamics and Market Insights

Updated Category News Views 107

Understanding Recent Trends in Intel's Options Market In recent times, significant investors, often referred to as 'whales', have shown a distinct bearish outlook on Intel. Their actions reflect a deeper narrative surrounding the stock and offer a glimpse into market sentiments. Upon analyzing the trading history for Intel (NASDAQ: INTC), we uncovered 31 trades that...

Continue Reading
Surging Growth in the Wasabi Market Driven by Health Benefits

Updated Category News Views 271

Exploring the Growth of the Wasabi Market As consumers become increasingly aware of the numerous health benefits associated with wasabi, the demand for this spicy condiment is on the rise. From 2025 to 2029, the global wasabi market is anticipated to grow by USD 422.2 million, reflecting a remarkable compound annual growth rate (CAGR) of 9.9%. This growth is largely...

Continue Reading
Abel Noser Solutions' Innovative Tool Recognized at Awards

Updated Category News Views 276

Abel Noser Solutions Wins Best Buy-Side TCA Tool Trading Technologies International, Inc. (TT), a leader in capital markets technology, recently announced a remarkable achievement: Abel Noser Solutions has earned the coveted title of Best Buy-Side TCA (Transaction Cost Analysis) Tool in the esteemed Buy-Side Technology Awards 2024. This recognition highlights Abel Noser's...

Continue Reading
Intuitive's Q1 Financial Highlights Show Strong Growth in Revenue

Updated Category News Views 237

Intuitive Surgical Reports Strong First Quarter Financial Performance Intuitive Surgical, a global innovator in robot-assisted surgery, has just unveiled its impressive financial results for the quarter ending March 31, 2025. The company's steady rise in revenue showcases its commitment to improving patient care through advanced technology. Key Highlights from Q1 Results...

Continue Reading